NEUE IMMUNKONJUGATE
European patent · EP2702074 · In force
Register entry
- Publication number
- EP2702074
- Application number
- EP12717674
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 26, 2012
- Published
- Mar 5, 2014
- Granted
- Nov 21, 2018
- Protection ends at the latest
- Apr 25, 2032
- Next annual fee due
- Apr 30, 2026
- IPC classes
- C07K 16/28 (2006.01)C07K 16/30 (2006.01)C07K 16/40 (2006.01)A61K 39/00 (2006.01)A61K 38/20 (2006.01)A61K 47/68 (2017.01)C07K 14/52 (2006.01)C07K 14/55 (2006.01)C07K 14/54 (2006.01)A61K 39/395 (2006.01)C07K 16/46 (2006.01)C07K 16/18 (2006.01)
- Priority
- EP 11164237 29.04.2011
- PCT application
- PCT/EP2012/057587 26.04.2012
- PCT publication
- WO2012/146628 01.11.2012
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 1, 2025
Change
Published in Swissreg on 01.05.2025
- May 1, 2024
Change
Published in Swissreg on 01.05.2024
- May 1, 2023
Change
Published in Swissreg on 01.05.2023
- Oct 19, 2021
Address changed
- Owner
- Roche Glycart AG, Wagistrasse 18, 8952 Schlieren → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren
Published in Swissreg on 19.10.2021
- Nov 21, 2018
Granted
Published in Swissreg on 21.11.2018
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.